Company

Pan Cancer T

Biotechnology Research Rotterdam, Zuid-holland, Nl 12 employees

Employees: 12
Contacts: 1
Emails: 1

www.pancancer-t.com LinkedIn Crunchbase

Pan Cancer T Overview

Headquarters: Rotterdam, Zuid-holland, Nl
Website: www.pancancer-t.com
Industry: Biotechnology Research
Employees: 12
Founded: 2020
Funding: 4.6M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Pan Cancer T

Pan Cancer T is a biotechnology spin-out (Erasmus MC, Rotterdam) focussed on the discovery and development of T cell receptor (TCR) T cell therapies. We exploit the 20 years of pioneering in adoptive T cell therapy as a springboard to breakthrough treatment of solid tumors. Pan Cancer T develops natural affinity TCR T cell therapies towards unique and proprietary intracellular targets expressed by multiple solid tumors, and make T cell therapy maximally accessible despite the tumor micro-environment challenges.

Pan Cancer T Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

Pan Cancer T Org Chart

Sample employees and titles

Name	Title	Location	Contact
Reno Debets	Professor in T-cell Immunity		View
Rachel Abbott	Chief Executive Officer at Pan Cancer T	Didcot, England, United Kingdom	Email
Dora Hammerl	Co-founder, VP R&D Pan Cancer T Bv	Leiden, South Holland, Netherlands	View
Reinout Hesselink, Phd	Accelerating Cell and Gene Therapies		View